Monday, 3 August 2026
340B rebate plan reintroduced, Cyclospora management challenges, Cambodia achieves HIV treatment targets
- 01
Trump administration reintroduces rebate plan for 340B program
The Trump administration announced plans to implement rebates in the 340B drug discount program starting in 2027. This marks the second attempt to impose such rebates after a previous pilot was scrapped due to legal challenges. The American Hospital Association expressed strong opposition, stating it would explore options to prevent the pilot from proceeding. The proposed changes come amid ongoing debates about the program's integrity and spending, which has surged to $100 billion.
via Healthcare Dive
- 02
Epidemiological challenges of Cyclospora worsened by US health agency cutbacks
The challenges in managing Cyclospora infections in the USA have intensified due to recent budget cuts at health agencies. These financial reductions have hindered efforts to effectively track and control the spread of the parasite, according to a report from Washington DC.
via The Lancet
- 03
Cambodia first in Asia-Pacific to achieve 95–95–95 HIV targets
Cambodia has become the first country in the Asia-Pacific region to reach the 95–95–95 targets for HIV treatment and care. This milestone raises hopes that other countries in the region may replicate its success. The achievement reflects significant progress in addressing HIV in Cambodia.
via The Lancet
- 04
New England Journal of Medicine Publishes on Obstructive Hypertrophic Cardiomyopathy
The New England Journal of Medicine has published an ahead-of-print article on obstructive hypertrophic cardiomyopathy. The article contributes to the ongoing research in this area, although specific findings and implications are not detailed in the source text. This publication may be relevant for clinicians involved in the management of patients with this condition.
via NEJM
- 05
New England Journal of Medicine publishes article on medical silence
An article titled 'Doctor’s Dirty Little Secret — The Cost of Silence' has been published in the New England Journal of Medicine. The piece addresses issues related to silence in the medical profession. Further details on the findings or implications are not provided in the source.
via NEJM
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.